Skip to main content
Toggle navigation
About Mainstay
About Reactiv8
For Clinicians
Home
Investors
News & Events
Careers
Contact Us
EN
FR
DE
NL
US
AU
News
Date
Title
22 Jun 2020
Mainstay Medical Announces U.S. FDA Approval of ReActiv8® Neurostimulation System for Chronic Low Back Pain
15 Feb 2018
Mainstay Releases 2017 Annual Report
24 Jun 2014
Mainstay Medical featured as Showcase Technology Company at the Tech Tour and International Venture Club’s HEALTHTECH Summit 2014.
14 Oct 2012
Mainstay Medical Limited Awarded Neurotech’s Golden Electrode Award for Most Promising Startup
×
Disclaimer
I am in the United States, Canada, Japan or Australia.